Tumour necrosis factor in man: clinical and biological observations.

Eighteen patients with advanced cancer have been treated intravenously with human recombinant tumour necrosis factor (rhTNF). The drug produced febrile reactions at all doses although these were preventable by steroids and indomethacin. Doses at or above 9 x 10(5) units (400 micrograms)m-2 were asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Selby, P., Hobbs, S., Viner, C., Jackson, E., Jones, A., Newell, D., Calvert, A. H., McElwain, T., Fearon, K., Humphreys, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1987
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002406/
https://www.ncbi.nlm.nih.gov/pubmed/3435706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002406/
https://www.ncbi.nlm.nih.gov/pubmed/3435706

Ejemplares similares